EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES As of the end of the period covered by this Annual Report on Form 40-F, an evaluation was carried out by our management, under the supervision, and with the participation, of our Chief Executive Officer (the “CEO”) and Chief Financial Officer (the “CFO”), of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based on that evaluation, the CEO and CFO concluded that such disclosure controls and procedures were effective and designed to ensure that material information relating to us and our consolidated subsidiaries would be made known to them by others within those entities. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING During the year ended December 31, 2003, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. IDENTIFICATION OF THE AUDIT COMMITTEE We have a separately-designated audit committee established in accordance with section 3(a)(58)(A) of the Securities Exchange Act of 1934. Our audit committee is comprised of four independent members: Norman M. Seagram, Don J. Morrison, Donald J. Lowry and Wesley Twiss. AUDIT COMMITTEE FINANCIAL EXPERT Our board of directors has determined that it has at least one audit committee financial expert serving on its audit committee. Wesley Twiss and Don Morrison have been determined to be audit committee financial experts and are independent, as that term is defined by the Nasdaq National Market’s listing standards. The U.S. Securities and Exchange Commission has indicated that the designation of these individuals as an audit committee financial expert does not make them an “expert” for any purpose, or impose any duties, obligations or liabilities that are greater than those imposed on members of the audit committee and board of directors who do not carry this designation or affect the duties, obligations or liabilities of any other member of the audit committee or board of directors. CODE OF ETHICS We have adopted a written Code of Business Conduct and Ethics (the “Code”) which governs the behaviour of our directors, officers, and employees. The Code also includes provisions required by theSarbanes-Oxley Act of 2002 that are applicable to our Chief Executive Officer, Chief Financial Officer and other senior financial officers. The board, through the Nomination and Corporate Governance Committee, oversees compliance with the Code. Any amendments or regulations any deviations from or amendments to the Code will be publicly disclosed. The Code is accessible on our investor relations web page atwww.hydrogenics.com.
-2-
|